Multifunctional polymeric nanoplatforms for brain diseases diagnosis, therapy and theranostics

Citation

Shakeri S, Ashrafizadeh M, Zarrabi A, et al., (2020) Multifunctional polymeric nanoplatforms for brain diseases diagnosis, therapy and theranostics. Biomedicines, Volume 8, Issue 1, January 2020, Article number 13

Abstract

The blood–brain barrier (BBB) acts as a barrier to prevent the central nervous system (CNS) from damage by substances that originate from the blood circulation. The BBB limits drug penetration into the brain and is one of the major clinical obstacles to the treatment of CNS diseases. Nanotechnology-based delivery systems have been tested for overcoming this barrier and releasing related drugs into the brain matrix. In this review, nanoparticles (NPs) from simple to developed delivery systems are discussed for the delivery of a drug to the brain. This review particularly focuses on polymeric nanomaterials that have been used for CNS treatment. Polymeric NPs such as polylactide (PLA), poly (D, L-lactide-co-glycolide) (PLGA), poly (ε-caprolactone) (PCL), poly (alkyl cyanoacrylate) (PACA), human serum albumin (HSA), gelatin, and chitosan are discussed in detail.

Description

Software Description

Software Language

Github

Keywords

blood–brain barrier (BBB), central nervous system (CNS), nanotechnology, drug delivery systems, polymeric nanoparticles, theranostics

DOI

Rights

Attribution 4.0 International

Relationships

Relationships

Supplements

Funder/s